🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06951477
Recruiting Observational

Gut Microbiome in Orthopaedics: Revision Total Knee Arthroplasty

NCT06951477 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2025-08-21
Last updated
2026-09-22

Condition(s) studied

Revision Total Knee ArthroplastyOsteoarthritis, Knee

Investigational drug(s) / intervention(s)

Revision Total Knee Arthroplasty

Revision Total Knee Arthroplasty: Study participants must be scheduled to receive a revision TKA.

Study summary

Many patients who receive knee replacement surgery must return for a revision (or repeat) surgery due to ongoing pain, stiffness, infection, or implant loosening. The role of the gut microbiome-the collection of bacteria and other microbes within the human gastrointestinal tract-is just beginning to be recognized in orthopaedics. The gut microbiome has been found to affect the immune response and bone regulation, potentially contributing to infection or loosening after total joint replacement. Antibiotics are regularly used in orthopaedic surgery to reduce the risk of infection, yet they might also harm gut microbiota and reduce their potentially beneficial effects. As a result, understanding the relationship between gut microbiota and surgical outcomes has become increasingly important. Therefore, this study aims to determine if there are differences in gut microbiota composition between patients with well-functioning knee replacements and those requiring revision knee replacements. Additional study aims include assessing inflammation, implant loosening, metal ion levels, and circulating bacteria in blood or tissue between well-functioning or failed knee replacements.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Scheduled to undergo a revision TKA * Willing and able to comply with follow-up requirements * Ability to provide informed consent * Ability to read, write, and speak English Exclusion Criteria: * Pregnancy * Less than 3 months post-operation from primary surgery * Diagnosis of periprosthetic fracture * Scheduled for DAIR (debridement, antibiotics, and implant retention) revision surgery * Scheduled for stage 2 PJI revision

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Hospital London Ontario Recruiting

More London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06951477 on ClinicalTrials.gov ↗ ← All trials in Canada